...
首页> 外文期刊>Acta pharmaceutica: a quarterly journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, dealing with all branches of pharmacy and allied sciences >Use of N, N-diethyl-p-phenylenediamine sulphate for the spectrophotometric determination of some phenolic and amine drugs
【24h】

Use of N, N-diethyl-p-phenylenediamine sulphate for the spectrophotometric determination of some phenolic and amine drugs

机译:N,N-二乙基对苯二胺硫酸盐用于分光光度法测定某些酚类和胺类药物的用途

获取原文
获取原文并翻译 | 示例

摘要

Spectrophotometric methods are proposed for the determination of drugs containing a phenol group [salbutamol sulphate (SLB), ritodrine hydrochloride (RTD), isoxsuprine hydrochloride (IXP)] and drugs containing an aromatic amine group [dapsone hydrochloride (DAP), sulfamethoxazole (SFM), and sulfadiazine (SFD)] in pharmaceutical dosage forms. The methods are based on coupling of N,N-diethyl-p-phenylenediamine sulphate with the drugs in the presence of KIO4 to give a green colored product (lmax at 670 nm) and a red colored product (lmax at 550 nm), respectively. Linear relationships with good correlation coefficients (0.9986-0.9996) were found between absorbance and the corresponding concentration of drugs in the range 1-7, 2-22, 1-17, 1.5-12, 2-25, and 2-21 mgmL-1 for SLB, RTD, IXP, DAP, SFM and SFD, respectively. Variable parameters such as temperature, reaction time and concentration of the reactants have been analyzed and optimized. The RSD of intra-day and inter-day studies was in the range of 0.2-1.0 and 0.4-1.0 %, respectively. No interference was observed from common pharmaceutical adjuvants. The reliability and performance of the proposed methods was validated statistically; the percentage recovery ranged from 99.5 ± 0.1 to 99.9 ± 0.3 %. Limits of detection were 0.14, 0.21, 0.51, 0.44, 0.33 and 0.37 μg mL-1 for SLB, RTD, IXP, DAP, SFM, and SFD, respectively.
机译:提出了分光光度法测定含有酚基团的药物[硫酸沙丁胺醇(SLB),盐酸利托君碱(RTD),盐酸异黄嘌呤(IXP)]和含有芳香胺基团的药物[盐酸氨苯砜(DAP),磺胺甲恶唑(SFM) ,以及磺胺嘧啶(SFD)]的药物剂型。该方法基于在KIO4存在下将N,N-二乙基-对苯二胺硫酸盐与药物偶联,分别得到绿色产物(在670 nm处的最大波长)和红色产物(在550 nm处的最大长度)。 。在吸光度和相应浓度的药物之间的线性关系具有良好的相关系数(0.9986-0.9996),范围为1-7、2-22、1-17、1.5-12、2-25和2-21 mgmL- 1分别用于SLB,RTD,IXP,DAP,SFM和SFD。已经分析和优化了可变参数,例如温度,反应时间和反应物浓度。日内和日间研究的RSD分别在0.2-1.0和0.4-1.0%的范围内。没有观察到普通药物佐剂的干扰。统计方法验证了所提方法的可靠性和性能。回收率从99.5±0.1到99.9±0.3%。 SLB,RTD,IXP,DAP,SFM和SFD的检出限分别为0.14、0.21、0.51、0.44、0.33和0.37μgmL-1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号